Screening of Tumor Antigens and Construction of Immune Subtypes for mRNA Vaccine Development in Head and Neck Squamous Cell Carcinoma

Background: A growing number of clinical studies have confirmed that mRNA vaccines are effective in the treatment of malignant tumors; however, their efficacy in head and neck squamous cell carcinoma (HNSCC) has not been determined. This study aimed to identify the potential antigens of HNSCC for mR...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hong-Xia, Liu, Tian-Run, Tu, Zhao-Xu, Xie, Chu-Bo, Wen, Wei-Ping, Sun, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855883/
https://www.ncbi.nlm.nih.gov/pubmed/36671475
http://dx.doi.org/10.3390/biom13010090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855883/
https://www.ncbi.nlm.nih.gov/pubmed/36671475
http://dx.doi.org/10.3390/biom13010090

Ejemplares similares